FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810059108> ?p ?o ?g. }

• W2810059108 endingPage "5122" @default.
• W2810059108 startingPage "5112" @default.
• W2810059108 abstract "Abstract Purpose: The advent of next-generation sequencing technologies has enabled the identification of several activating mutations of Erb-B2 receptor tyrosine kinase 2 (ERBB2) among various cancers. However, the significance of infrequent mutations has not been fully investigated. Herein, we comprehensively assessed the functional significance of the ERBB2 mutations in a high-throughput manner. Experimental Design: We evaluated the transforming activities and drug sensitivities of 55 nonsynonymous ERBB2 mutations using the mixed-all-nominated-in-one (MANO) method. Results: G776V, G778_S779insG, and L841V were newly revealed to be activating mutations. Although afatinib, neratinib, and osimertinib were shown to be effective against most of the ERBB2 mutations, only osimertinib demonstrated good efficacy against L755P and L755S mutations, the most common mutations in breast cancer. In contrast, afatinib and neratinib were predicted to be more effective than other inhibitors for the A775_776insYVMA mutation, the most frequent ERBB2 mutation in lung cancer. We surveyed the prevalence of concurrent ERBB2 mutation with gene amplification and found that approximately 30% of ERBB2-amplified urothelial carcinomas simultaneously carried ERBB2 mutations, altering their sensitivity to trastuzumab, an mAb against ERBB2. Furthermore, the MANO method was applied to evaluate the functional significance of 17 compound mutations within ERBB2 reported in the COSMIC database, revealing that compound mutations involving L755S were sensitive to osimertinib but insensitive to afatinib and neratinib. Conclusions: Several ERBB2 mutations showed varying sensitivities to ERBB2-targeted inhibitors. Our comprehensive assessment of ERBB2 mutations offers a fundamental database to help customize therapy for ERBB2-driven cancers. We identified several ERBB2 mutations as activating mutations related to tumorigenesis. In addition, our comprehensive evaluation revealed that several ERBB2 mutations showed varying sensitivities to ERBB2-targeted inhibitors, and thus, the functional significance of each variant should be interpreted precisely to design the best treatment for each patient. Clin Cancer Res; 24(20); 5112–22. ©2018 AACR." @default.
• W2810059108 created "2018-07-10" @default.
• W2810059108 creator A5032033606 @default.
• W2810059108 creator A5051860337 @default.
• W2810059108 creator A5055160098 @default.
• W2810059108 creator A5068011989 @default.
• W2810059108 creator A5074950427 @default.
• W2810059108 creator A5087920662 @default.
• W2810059108 creator A5090361788 @default.
• W2810059108 creator A5090560513 @default.
• W2810059108 date "2018-10-15" @default.
• W2810059108 modified "2023-10-03" @default.
• W2810059108 title "High-Throughput Functional Evaluation of Variants of Unknown Significance in <i>ERBB2</i>" @default.
• W2810059108 cites W1867948347 @default.
• W2810059108 cites W1966996035 @default.
• W2810059108 cites W1991905225 @default.
• W2810059108 cites W1994499102 @default.
• W2810059108 cites W2018178643 @default.
• W2810059108 cites W2026347115 @default.
• W2810059108 cites W2037013151 @default.
• W2810059108 cites W2038081635 @default.
• W2810059108 cites W2049449785 @default.
• W2810059108 cites W2075177970 @default.
• W2810059108 cites W2077860295 @default.
• W2810059108 cites W2085470185 @default.
• W2810059108 cites W2095156669 @default.
• W2810059108 cites W2095659509 @default.
• W2810059108 cites W2110444464 @default.
• W2810059108 cites W2112854176 @default.
• W2810059108 cites W2113762115 @default.
• W2810059108 cites W2120921373 @default.
• W2810059108 cites W2123696077 @default.
• W2810059108 cites W2130479718 @default.
• W2810059108 cites W2135051816 @default.
• W2810059108 cites W2148479421 @default.
• W2810059108 cites W2159192794 @default.
• W2810059108 cites W2163250226 @default.
• W2810059108 cites W2166199281 @default.
• W2810059108 cites W2251851976 @default.
• W2810059108 cites W2279474619 @default.
• W2810059108 cites W2280175247 @default.
• W2810059108 cites W2318605753 @default.
• W2810059108 cites W2416365238 @default.
• W2810059108 cites W2484071785 @default.
• W2810059108 cites W2487112402 @default.
• W2810059108 cites W2529854314 @default.
• W2810059108 cites W2584922809 @default.
• W2810059108 cites W2592465655 @default.
• W2810059108 cites W2595645511 @default.
• W2810059108 cites W2598622710 @default.
• W2810059108 cites W2613362156 @default.
• W2810059108 cites W2613784923 @default.
• W2810059108 cites W2726739357 @default.
• W2810059108 cites W2747965175 @default.
• W2810059108 cites W2769659311 @default.
• W2810059108 cites W2773354488 @default.
• W2810059108 cites W2775672838 @default.
• W2810059108 cites W2781759361 @default.
• W2810059108 cites W2783112448 @default.
• W2810059108 cites W2785610956 @default.
• W2810059108 cites W2809294922 @default.
• W2810059108 doi "https://doi.org/10.1158/1078-0432.ccr-18-0991" @default.
• W2810059108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29967253" @default.
• W2810059108 hasPublicationYear "2018" @default.
• W2810059108 type Work @default.
• W2810059108 sameAs 2810059108 @default.
• W2810059108 citedByCount "55" @default.
• W2810059108 countsByYear W28100591082018 @default.
• W2810059108 countsByYear W28100591082019 @default.
• W2810059108 countsByYear W28100591082020 @default.
• W2810059108 countsByYear W28100591082021 @default.
• W2810059108 countsByYear W28100591082022 @default.
• W2810059108 countsByYear W28100591082023 @default.
• W2810059108 crossrefType "journal-article" @default.
• W2810059108 hasAuthorship W2810059108A5032033606 @default.
• W2810059108 hasAuthorship W2810059108A5051860337 @default.
• W2810059108 hasAuthorship W2810059108A5055160098 @default.
• W2810059108 hasAuthorship W2810059108A5068011989 @default.
• W2810059108 hasAuthorship W2810059108A5074950427 @default.
• W2810059108 hasAuthorship W2810059108A5087920662 @default.
• W2810059108 hasAuthorship W2810059108A5090361788 @default.
• W2810059108 hasAuthorship W2810059108A5090560513 @default.
• W2810059108 hasBestOaLocation W28100591082 @default.
• W2810059108 hasConcept C104317684 @default.
• W2810059108 hasConcept C121608353 @default.
• W2810059108 hasConcept C141231307 @default.
• W2810059108 hasConcept C149904235 @default.
• W2810059108 hasConcept C2777626846 @default.
• W2810059108 hasConcept C2778087573 @default.
• W2810059108 hasConcept C2779413316 @default.
• W2810059108 hasConcept C2779438470 @default.
• W2810059108 hasConcept C2779786085 @default.
• W2810059108 hasConcept C2780586478 @default.
• W2810059108 hasConcept C2781187634 @default.
• W2810059108 hasConcept C501734568 @default.
• W2810059108 hasConcept C502942594 @default.
• W2810059108 hasConcept C530470458 @default.
• W2810059108 hasConcept C54355233 @default.

• next